Rh
NYSE:RHSpecialty Retail
+$7.55 today
- Market cap
- $2.22B
- Beta
- 1.90
- P/E (TTM)
- 26.2
- EPS (TTM)
- $5.47
Volume 0.68M
Average 1.22M
RH Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
RhNYSE: RH
Research & Development · Q2 FY2026 · quarter ended Aug 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-31 | 0 | — |
| FY2024 | 2025-01-31 | 0 | — |
| FY2023 | 2024-01-31 | 0 | — |
| FY2022 | 2023-01-31 | 0 | — |
| FY2021 | 2022-01-31 | 0 | — |
Research & Development vs competitors
How RH compares with its peers on the latest reported figures
- RH's LTM Aug 2026 research & development of $0 is the 2nd highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for RH, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $149.69M | -4.2% | +8.0% | 15.1% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM May 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding RH) | $0 | -4.2% | +8.0% | 0.0% | |
Competitors are the stored peer set for RH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Jan 2024 | FY2024 Jan 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 3.76B | 3.59B | 3.03B | 3.18B | 3.44B |
| Cost of Revenue | 1.9B | 1.78B | 1.64B | 1.77B | 1.92B |
| Gross Profit | 1.86B | 1.81B | 1.39B | 1.41B | 1.52B |
| Gross Margin | 49.4% | 50.5% | 45.9% | 44.5% | 44.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 922.34M | 1.07B | 1.03B | 1.05B | 1.13B |
| Operating Expenses | 922.34M | 1.07B | 1.03B | 1.05B | 1.13B |
| Depreciation & Amortization | 168.5M | 183.77M | 118.99M | 130.19M | 148.5M |
| EBITDA | 1.07B | 774.84M | 523.59M | 453.28M | 540.82M |
| EBITDA Margin | 28.4% | 21.6% | 17.3% | 14.3% | 15.7% |
| Operating Income | 933.08M | 746.08M | 363.18M | 367.76M | 387.27M |
| Operating Margin | 24.8% | 20.8% | 12.0% | 11.6% | 11.3% |
| Interest Income | 1.94M | 38.52M | 39.6M | 3.9M | 0 |
| Interest Expense | 66.88M | 151.73M | 237.9M | 234.5M | 225.38M |
| Other Income / Expenses | (110.97M) | (308.79M) | (207.36M) | (290.54M) | (220.33M) |
| Income Before Tax | 822.1M | 437.28M | 155.82M | 77.21M | 166.94M |
| Pre-Tax Margin | 21.9% | 12.2% | 5.1% | 2.4% | 4.9% |
| Income Tax Expense | 133.56M | (91.36M) | 28.26M | 4.8M | 42.15M |
| Net Income | 688.55M | 528.64M | 127.56M | 72.41M | 124.79M |
| Net Margin | 18.3% | 14.7% | 4.2% | 2.3% | 3.6% |
| EPS (Basic) | 32.37 | 22.47 | 6.42 | 3.92 | 6.65 |
| EPS (Diluted) | 22.13 | 19.90 | 5.91 | 3.62 | 6.31 |
| Weighted Avg Shares | 21.27M | 23.52M | 19.88M | 18.49M | 18.75M |
| Weighted Avg Shares (Diluted) | 31.11M | 26.56M | 21.6M | 19.99M | 19.79M |
Rh
NYSE:RH
Intrinsic Alpha fair value
Locked
Current Price
$117.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.